October 15, 2021

Within3 on the MAPS Elevate Podcast

What is the insight gap, and why should you care? Within3’s Lance Hill and Mike Abbadessa discuss how life science companies could be missing out on important insight.
What is the insights gap?

What is the insight gap, and why should you care? In a recent MAPS Elevate podcast episode, Within3 CEO Lance Hill and Executive Director, Medical Affairs Mike Abbadessa talk about how life science companies might be missing out on critical information by viewing insight-gathering as a set of actions rather than a holistic process. While engaging KOLs to generate data point observations is an important part of the insight collection process, it’s not a standalone activity.

For medical affairs, clinical, and commercial teams, insight-gathering is a painstaking – and sometimes painful – process. Sources of insight might include large-scale events like medical congresses, regular advisory board meetings, and one-on-one KOL meetings. Data from all of these interactions end up in different systems or documents and is siloed across the organization, even among teams that work together closely. This creates insight gaps that lead teams to base decisions on outdated or irrelevant information.

This fragmented approach results in a lot of manual work, slowing down the product development process and costing billions. In this discussion, Hill and Abbadessa talk about the importance of proper insights management, how technology can enable a more unified approach, and how life science teams stand to benefit.

Listen to the MAPS Elevate podcast episode “What is the insight gap, and why should you care?”

Related Posts:

Modern insights management

Within3 on MAPS: Modern Insights Management

Medical affairs organizations can modernize their operations in the pre-launch and launch phase by harnessing insights management technology.
within3 pharmaceutical commerce podcast

Lance Hill on the Pharmaceutical Commerce podcast

Life science companies should look at a modern, tech-enabled process for gathering insight.
approach to artificial intelligence

Within3 in Datanami: how pharma should think about AI

A company’s decision on how to apply AI significantly impacts the outcome of AI investment.